Visentin Virgile, Prévot Danielle, Marti Luc, Carpéné Christian
Institut Louis Bugnard, Institut National de la Santé et de la Recherche Médicale, Unité 586, C.H.U. Rangueil, Toulouse Cedex F-31403, France.
Eur J Pharmacol. 2003 Apr 18;466(3):235-43. doi: 10.1016/s0014-2999(03)01562-0.
It has been demonstrated that amine oxidase substrates stimulate glucose transport in cardiomyocytes and adipocytes, promote adipogenesis in pre-adipose cell lines and lower blood glucose in diabetic rats. These insulin-like effects are dependent on amine oxidation by semicarbazide-sensitive amine oxidase or by monoamine oxidase. The present study aimed to investigate whether amine oxidase substrates also exhibit another insulin-like property, the inhibition of lipolysis. We therefore tested the influence of tyramine and benzylamine on lipolytic activity in rat adipocytes. These amines did not modify basal lipolysis but dose-dependently counteracted the stimulation induced by lipolytic agents. The response to 10 nM isoprenaline was totally inhibited by tyramine 1 mM. The blockade produced by inhibition of amine oxidase activity or by 1 mM glutathione suggested that the generation of oxidative species, which occurs during amine oxidation, was involved in tyramine antilipolytic effect. Among the products resulting from amine oxidation, only hydrogen peroxide was antilipolytic in a manner that was potentiated by vanadate, as for tyramine or benzylamine. Antilipolytic responses to tyramine and to insulin were sensitive to wortmannin. These data suggest that inhibition of lipolysis is a novel insulin-like effect of amine oxidase substrates which is mediated by hydrogen peroxide generated during amine oxidation.
已证实胺氧化酶底物可刺激心肌细胞和脂肪细胞中的葡萄糖转运,促进前脂肪细胞系中的脂肪生成,并降低糖尿病大鼠的血糖。这些胰岛素样作用取决于氨基脲敏感胺氧化酶或单胺氧化酶的胺氧化作用。本研究旨在调查胺氧化酶底物是否还表现出另一种胰岛素样特性,即抑制脂肪分解。因此,我们测试了酪胺和苄胺对大鼠脂肪细胞中脂肪分解活性的影响。这些胺并未改变基础脂肪分解,但能剂量依赖性地抵消脂肪分解剂诱导的刺激。1 mM酪胺可完全抑制对10 nM异丙肾上腺素的反应。抑制胺氧化酶活性或1 mM谷胱甘肽产生的阻断作用表明,胺氧化过程中产生的氧化物质参与了酪胺的抗脂肪分解作用。在胺氧化产生的产物中,只有过氧化氢具有抗脂肪分解作用,其作用方式与酪胺或苄胺一样,可被钒酸盐增强。对酪胺和胰岛素的抗脂肪分解反应对渥曼青霉素敏感。这些数据表明,抑制脂肪分解是胺氧化酶底物的一种新的胰岛素样作用,它由胺氧化过程中产生的过氧化氢介导。